Farallon Capital Management LLC Voyager Therapeutics, Inc. Transaction History

Farallon Capital Management LLC

$20.7 Billion
Q2 2024

A detailed history of Farallon Capital Management LLC transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Farallon Capital Management LLC holds 2,292,000 shares of VYGR stock, worth $13.4 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

2,292,000

Holding current value

$13.4 Million

% of portfolio

0.09%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$7.15 - $10.84 $7.15 Million - $10.8 Million	1,000,000 Added 77.4%	2,292,000 $21.3 Million
Q4 2023 Feb 14, 2024	BUY	$6.28 - $8.81 $8.11 Million - $11.4 Million	1,292,000 New	1,292,000 $10.9 Million
Q3 2023 Nov 14, 2023	BUY	$7.55 - $11.25 $9.75 Million - $14.5 Million	1,292,000 New	1,292,000 $10 Million
Q2 2023 Aug 14, 2023	BUY	$6.94 - $13.99 $3.44 Million - $6.93 Million	495,000 Added 62.11%	1,292,000 $14.8 Million
Q1 2023 May 15, 2023	BUY	$6.0 - $10.78 $4.78 Million - $8.59 Million	797,000 New	797,000 $6.14 Million
Q2 2019 Aug 14, 2019	SELL	$19.18 - $27.88 $4.8 Million - $6.97 Million	-250,158 Reduced 25.01%	750,000 $20.4 Million
Q1 2019 May 15, 2019	BUY	$8.0 - $19.66 $728,000 - $1.79 Million	91,000 Added 10.01%	1,000,158 $19.1 Million
Q3 2018 Nov 14, 2018	BUY	$17.11 - $21.74 $2.41 Million - $3.07 Million	141,001 Added 18.36%	909,158 $17.2 Million
Q2 2018 Aug 14, 2018	SELL	$16.76 - $23.92 $2.04 Million - $2.91 Million	-121,843 Reduced 13.69%	768,157 $15 Million
Q1 2018 May 15, 2018	BUY	$16.16 - $31.31 $3.8 Million - $7.36 Million	235,188 Added 35.92%	890,000 $16.7 Million
Q4 2017 Feb 14, 2018	BUY	$12.26 - $25.88 $5.97 Million - $12.6 Million	487,147 Added 290.55%	654,812 $10.9 Million
Q3 2017 Nov 14, 2017	BUY	$8.37 - $20.59 $1.4 Million - $3.45 Million	167,665	167,665 $3.45 Million

Others Institutions Holding VYGR

# of Institutions

128

Shares Held

36.7M

Call Options Held

48K

Put Options Held

36.2K

View Full List

About Voyager Therapeutics, Inc.

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $226M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

More about VYGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.

Account

Farallon Capital Management LLC Voyager Therapeutics, Inc. Transaction History